• Portfolio Facts
  • Sub-Adviser: Morgan Stanley Investment Mgmt
  • PortfolioManagers: Dennis P. Lynch; David S. Cohen; Sam G. Chainani, CFA; Alexander T. Norton; Jason C. Yeung, CFA; Armistead B. Nash
  • Investment Objective: Seeks capital appreciation.
  • Inception Date: 03-01-1993
  • Net Assets (03-31-2014): $824,844,854

As of 03-31-2014
One Year27.61%
Three Year 9.39%
Five Year 25.53%
Ten Year 9.66%
Since Inception 10.90%

The Average Annual Returns reflect the advisory fee and all other portfolio expenses and include reinvestment of dividends and capital gains; they do not reflect the charges and deduction under the applicable life insurance policies or annuity contracts. This information must be accompanied by the current performance reports for the appropriate product showing returns net of fees and charges, including mortality and expense risk charge. Past performance is no guarantee of future performance. Both the return and principal value of subaccounts will fluctuate so that when redeemed, they may be worth more or less than their original cost. An investment in the fund is subject to risk including possible loss of principal.

Investing in medium-sized companies involves greater risk than is customarily associated with more established companies. Stocks of such companies may be subject to more abrupt or erratic price movements than larger company securities. Such companies usually do not pay significant dividends that could cushion returns in a failing market.

As of 03-31-2014
Domestic Equity 84.44%
Foreign Equity 10.95%
Cash & Cash Equivalent 4.60%
As of 03-31-2014
Information Technology 30.90%
Health Care 17.23%
Consumer Discretionary 16.97%
Industrials 14.82%
Consumer Staples 6.99%
Financials 6.30%
Materials 1.14%
Energy 0.92%
As of 03-31-2014
Illumina, Inc., 4.046% 6.18%
State Street Corp., 0.010%, due 04/01/2014 4.60%
athenahealth, Inc., 6.189% 3.32%
Intuitive Surgical, Inc., 1.878% 3.21%
Solera Holdings, Inc., 1.001% 2.90%
Motorola Solutions, Inc., 1.850% 2.85%
Tesla Motors, Inc., 0.263% 2.75%
Mead Johnson Nutrition Co., 1.673%, Class A 2.71%
Edenred, 3.655% 2.57%
Gartner, Inc., 1.475% 2.54%